Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update
September 01, 2023 17:57 ET
|
Turnstone Biologics Corp.
Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy programsCash position expected to fund operations into second quarter of...
Global CAR T-Cell Therapy Market Size on a Meteoric Rise: Envisioning $2406.39 Million by 2030 with a Striking CAGR of 26.20%
August 23, 2023 04:51 ET
|
Zion Market Research
New York, NY, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “CAR T-Cell Therapy Market By Drug Type (Axicabtagene Ciloleucel, Brexucabtagene...
Gemcitabine HCL Market to Achieve CAGR of 7.4%, Exceeding US$ 1.3 Bn by 2031
July 26, 2023 09:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, July 26, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The gemcitabine HCL market was valued at US$ 635.1 Mn in 2021 and is projected to exceed...
Elevar Therapeutics Announces Publication of Phase 3 CARES 310 Study Results in The Lancet
July 24, 2023 21:39 ET
|
Elevar Therapeutics
FORT LEE, N.J., July 24, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating...
Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering
July 21, 2023 02:15 ET
|
Turnstone Biologics Corp.
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing new medicines to treat and cure...
Elevar Therapeutics Announces FDA Acceptance for Filing of New Drug Application for Rivoceranib in Combination with Camrelizumab as a First-line Treatment for Unresectable Hepatocellular Carcinoma
July 17, 2023 09:00 ET
|
Elevar Therapeutics
FORT LEE, N.J., July 17, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd., and a fully integrated biopharmaceutical company dedicated to elevating...
"The Future of Medical Procedures: Understanding the Radiofrequency Ablation Devices Market (+CAGR of 11.6%) ", Says Market.us
July 05, 2023 08:59 ET
|
Market.Us
New York, July 05, 2023 (GLOBE NEWSWIRE) -- The Radiofrequency Ablation Devices Market in terms of revenue was estimated to be worth USD 4.3 Bn in 2022 and is poised to reach USD 12.5 Bn by 2032,...
Antibody Drug Conjugates Market to surpass USD 26.5 billion by 2032, says Global Market Insights Inc.
June 20, 2023 20:00 ET
|
Global Market Insights Inc.
Selbyville, Delaware, June 20, 2023 (GLOBE NEWSWIRE) -- Antibody Drug Conjugates Market size will cross USD 26.5 billion by 2032. Growing advancements in antibody engineering and conjugation...
Thermosome Announces Participation in IMAGIO Consortium to Improve Cancer Treatment
June 20, 2023 04:00 ET
|
AKAMPION
IMAGIO consortium of clinical partners coordinated by Philips receives EUR 24 million grant from the Innovative Health Initiative (IHI) and additional funding from industry partners to support the...
Hyperthermia Cancer Treatment Market to Grow 5.9% CAGR, Worth US$ 266 Million by 2030 | TMR Study
June 02, 2023 08:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, June 02, 2023 (GLOBE NEWSWIRE) -- The global hyperthermia cancer treatment market stood at US$ 147.6 million in 2019 and the global market is projected to reach...